Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • School Stories
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Elections

Don't Miss

Don't Miss:

  • Support GPB Today
  • Podcast: Manufacturing Danger: The BioLab Story
  • TV Highlights This Week

News Articles: remdesivir

Pfizer's Paxlovid combines two antiviral drugs to fight the virus that causes COVID-19.

Tagged as: 

  • Health

In a pandemic milestone, the NIH ends guidance on COVID treatment

The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.

March 19, 2024
|
By:
  • Pien Huang
Drugmaker Gilead says remdesivir has proved effective at treating patients early in the course of the disease.

Tagged as: 

  • Health Care

Why remdesivir, a highly effective COVID treatment, is a last resort for providers

The antiviral infusion was just revived as an early treatment for COVID patients. But the drug is relatively expensive and hard to administer, relegating it to what some are calling "stopgap" status.

February 08, 2022
|
By:
  • Pien Huang
Boxes containing vials of remdesivir at a pharmaceutical company in Giza, Egypt.

Tagged as: 

  • Global Health

WHO Trial Finds Remdesivir Has 'No Meaningful Effect' In COVID-19 Patients

The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority.

November 20, 2020
|
By:
  • Jason Beaubien
In this photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, Ind. On Monday, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it is unlikely to help.

Tagged as: 

  • Medical Treatments

Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On

The trial studied the efficacy of bamlanivimab in combination with the antiviral remdesivir on hospitalized COVID-19 patients. Researchers concluded the antibody treatment was "unlikely to help."

October 27, 2020
|
By:
  • Vanessa Romo
Boxes of remdesivir<em>,</em> an antiviral drug considered a promising treatment for COVID-19.

Tagged as: 

  • Global Health

Ironic Twist: In Spring, Trump Halted Research Key To COVID-19 Drug He's Now Taken

The drug remdesivir emerged in part because researchers had previously tested it in China through a project whose grant was abruptly ended by the National Institutes of Health.

October 08, 2020
|
By:
  • Nurith Aizenman
Dr. Sean Dooley briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md. on Saturday. Trump was admitted to the hospital after contracting the coronavirus.

Tagged as: 

  • Science

Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus

President Trump is on day two of a planned 5-day course of remdesivir. The medication, approved for treating COVID-19, works by making it harder for the coronavirus to replicate within the body.

October 04, 2020
|
By:
  • Matthew S. Schwartz
Niticia Mpanga, a registered respiratory therapist, checks on an ICU patient at Oakbend Medical Center in Richmond, Texas. The mortality rates from COVID-19 in ICUs have been decreasing worldwide, doctors say, at least partly because of recent advances in treatment.

Tagged as: 

  • Health

Advances In ICU Care Are Saving More Patients Who Have COVID-19

One thing that has improved a lot over the course of the pandemic is treatment of seriously ill COVID-19 patients in intensive care units. Here's one man's success story.

September 20, 2020
|
By:
  • Richard Harris
The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there's not enough of the medicine to go around.

Tagged as: 

  • Health

How Feds Decide On Remdesivir Shipments To States Remains Mysterious

The federal government is in charge of distributing one of the few treatment options for COVID-19: the antiviral drug remdesivir. But how are decisions made about which states need it most?

August 19, 2020
|
By:
  • Sydney Lupkin
A man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences Inc.

Tagged as: 

  • Health

Drug Company To Charge Thousands For COVID-19 Treatment

A five-day course of the antiviral drug remdesivir will cost private health insurers in the United States more than $3,000, Gilead Chairman & CEO...

June 29, 2020
|
By:
  • Ellen Eldridge
A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, March 11, 2020.

More Of The Antiviral Drug Remdesivir Shipping To Georgia Hospitals

A second shipment of the antiviral drug remdesivir is heading to 29 Navicent, Northside, Piedmont and WellStar hospitals, the state health department...

May 21, 2020
|
By:
  • Ellen Eldridge
FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington.

Georgia Hospitals Receive Remdesivir To Treat COVID-19 Patients

Though not approved by the Food and Drug Administration, the Georgia Department of Public Health is distributing the antiviral medication remdesivir to...

May 16, 2020
|
By:
  • Ellen Eldridge

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2025, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®